Clinical Trials Logo
  1. Home
  2. Pulmonary Embolism
  3. NCT04980924
  4. Details
NCT04980924 Clinical Trial

Epidemiology and Clinical Course of Pulmonary Embolism During and After Hospitalisation

Pulmonary Embolism Clinical Trial

— REMATEV  

Official title:
Pulmonary Embolism Registry

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04980924
Other study ID # 21cardio01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 1992
Est. completion date December 31, 2030

Study information
Verified date July 2021
Source Centre Hospitalier Universitaire de Nice
Contact emile Ferrari, PUPH
Phone 33492037735
Email ferrari.e@chu-nice.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Recruitment information / eligibility
Status Recruiting
Enrollment 2500
Est. completion date December 31, 2030
Est. primary completion date December 31, 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years to 110 Years
Eligibility Inclusion Criteria: - All pulmonary embolisms hospitalised in Nice hospital. - acceptation to enter in the cohorte survey Exclusion Criteria: -

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no intervention
no intervention

Locations
Country Name City State
France Nice University Hospital Nice

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Reccurence number of patient with Documented symptomatic pulmonary embolism reccurence 10 years
Secondary Pulmonary hypertension number of patients with Confirmed pulmonary hypertension after pulmonary embolism 10 years
Secondary Chronic pulmonary disease without hypertension number of patients with dyspnea but without pulmonary hypertension, Documented non-reperfused pulmonary areas 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT05050617 - Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Completed NCT03915925 - Short-term Clinical Deterioration After Acute Pulmonary Embolism
Completed NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT04454554 - Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
Completed NCT03173066 - Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography Phase 1
Terminated NCT03002467 - Impact Analysis of Prognostic Stratification for Pulmonary Embolism N/A
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT02611115 - Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. N/A
Completed NCT01975090 - The SENTRY Clinical Study N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT01326507 - Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism N/A
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00780767 - Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism Phase 2
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00816920 - Natural History of Isolated Deep Vein Thrombosis of the Calf